Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients

Launched by CAIRO UNIVERSITY · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two different daily supplements—Omega-3 and Vitamin D—on patients receiving treatment for a specific type of gum disease called stage II grade B periodontitis. The goal is to see if these supplements can help improve the healing process alongside active periodontal therapy. The trial is currently recruiting participants aged 25 and older who are generally healthy and have not received any recent gum treatments or surgeries.

To be eligible for the study, participants must have a certain level of gum disease and good oral hygiene. They should not be taking medications that could affect their gum health, and they must not have any conditions that could interfere with healing, like diabetes. Participants can expect to receive either Omega-3 or Vitamin D daily, along with standard gum disease treatment, and will be monitored throughout the study. It is important to note that individuals who are pregnant, breastfeeding, or have recently used similar supplements are not eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Systemic healthy patients
• • Patients aged \> 25 years
• • Patients suffering from stage II periodontitis with grade B were included in this study, according to 2017 world workshop classification of periodontal disease (Papapanou et al. 2017).
• • Patients with interdental clinical attachment loss (CAL) of 3-4 mm
• • No history of previous periodontal therapy.
• • No taken medications known to interfere healing or periodontal tissue health such as anticonvulsants, calcium channel blockers, or immunosuppressant drugs.
• • No previous periodontal surgery at involved sites.
• • Good oral hygiene and good compliance with the plaque control instructions following initial therapy.
• • Neither taken antibiotics within the last three months nor nonsteroidal anti-inflammatory drugs within the last three months
• • Absence of diseases or conditions that would interfere with wound healing such as diabetes mellitus or coagulation disorders
• • Absence of oral mucosal inflammatory conditions such as aphthous ulcers or lichen planus.
• Exclusion Criteria:
• • • Patients taking Omega- 3 or Vitamin D as a nutritional supplement were excluded from the study
• • Smoking habits
• • Pregnant and lactating mothers
• • Patients who have been received periodontal surgery in the study area during the last 6 months.